Novo and Oxford University collaborate in research and development partnership for type 2 diabetes
Novo Nordisk and Oxford University have struck a type 2 diabetes research partnership that will see the pharma company invest £115 million in a research base in the city. The partnership will allow scientists from the two organisations to collaborate on discovering innovative treatments for type 2 diabetes. Novo is also investing in a new